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Objectives This study sought to analyze recent trends over time in heart failure (HF) hospital stay rates, length of stay (LOS),
and in-hospital mortality by age groups with a large national dataset of U.S. hospital discharges.
Background Heart failure hospital stay rates, LOS, and mortality have fallen over the past decade for older Medicare benefi-
ciaries, but whether this holds true for younger adults is unknown.
Methods From the National Inpatient Sample, we calculated HF hospital stay rates, LOS, and in-hospital mortality from
2001 to 2009 with survey data analysis techniques.
Results Hospital stays (n  1,686,089) with a primary discharge diagnosis of HF were identified from National Inpatient
Sample data between 2001 and 2009. The overall national hospital stay rate decreased from 633 to 463 hospi-
tal stays/100,000 persons, (26.9%, p-for-trend 0.001). However, statistically significant declines (p  0.001)
were only observed for patients 55 to 64 years of age (36.5%) 65 to 74 years (37.4%), and 75 years
(28.3%) but not for patients 18 to 44 years of age (12.8%, p  0.57) or 45 to 55 years (16.2%, p  0.04).
Statistically significant declines in LOS were only observed for patients 65 years of age and older. Overall
in-hospital mortality fell from 4.5% to 3.3%, a relative decline of 27.4%, (p-for-trend 0.001), but patients 18
to 44 years of age did not exhibit a significant decline (8.1%, p-for-trend  0.18). In secondary analyses signifi-
cant declines in HF hospital stay rate over time were observed for white men, white women, and black women
but not for black men (9.5%, p-for-trend  0.43).
Conclusions Younger patients have not experienced comparable declines in HF hospital stay, LOS, and in-hospital mortality
as older patients. Black men remain a vulnerable population for HF hospital stay. (J Am Coll Cardiol 2013;61:
1078–88) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.057The heart failure (HF) hospital stay rate has dropped
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2012, accepted November 28, 2012.tion (1)—nearly 30% from 1998 to 2008—implying some
success in preventative efforts. However, the etiology of HF
often differs between younger adults and older Medicare
beneficiaries. Hypertension is the most common etiology of
HF in younger adults (2), whereas coronary artery disease
becomes a more common risk factor for HF among middle-
aged and older patients (3,4). In addition, as age increases,
the prevalence of HF with preserved ejection fraction rises
dramatically, in conjunction with comorbid risk factors such
as hypertension, atrial fibrillation, diabetes mellitus, and
renal insufficiency (3,5,6). As such, declines in the HF
hospital stay rate observed for older Medicare patients
might not necessarily indicate a corresponding decrease for
younger populations. Whether HF hospital stay rates differ
across age groups in the U.S. population is unknown and
the focus of this study.
In addition, we have a limited understanding of how HF
hospital stay rates have changed over time across race-sex
groups. One study of the Medicare population found that
HF hospital stay rates declined at a slower rate for black
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patients are more likely to develop HF at younger ages than
white patients (2), and whether this affects differences across
race with respect to declines in HF hospital stays is
unknown. Furthermore, black patients represent a higher
roportion of the uninsured and Medicaid enrollees (7),
hich might potentially lead to differences in HF hospi-
al stays across race compared with studies examining
edicare data alone. As such, confirming whether black
en had slower declines in HF hospital stay rate in the
eneral population is important, because it might indicate
hat this group is a particularly vulnerable population that
ould benefit from targeted preventative efforts against
F risk factors (8,9).
Accordingly, we analyzed data from the National Inpa-
ient Sample (NIS), a large national dataset of acute care
ospital stays that includes all age groups and all types of
ealth insurance coverage to examine changes across patient
ge categories in HF hospital stay rates, length of stay
LOS), and in-hospital mortality between 2001 and 2009.
econdary analyses examined trends in HF hospital stay by
ace-sex categories.
ethods
ata. The NIS, collected by the Agency for Healthcare
esearch and Quality Healthcare Cost and Utilization
roject, is the largest all-payer inpatient database publicly
vailable in the United States. Consisting of discharge data
rom over 1,000 hospitals across 44 states, the NIS was
esigned to approximate a 20% stratified sample of U.S.
ommunity hospitals (10). Statistical sampling weights pro-
ided by the NIS allow extrapolation to calculate expected
ospital stay rates for the nation (11). The NIS data were
ollected on all patients, regardless of health insurance
rovider. The following NIS fields were used for this
nalysis: patient age, sex, race, principal and secondary
iagnosis codes, admission date, discharge date, in-hospital
eath, insurance status, and state of hospital stay. Secondary
nalyses stratified by race-sex categories were conducted in
subset of patients hospitalized in states that reported
omplete data on patient race across all years to the NIS.
tudy cohort. A total of 71,371,439 hospital discharges
ere reported to the NIS from 2001 to 2009 from 44 states
eporting data to NIS. We excluded the following hospital
tays: discharges in which patient age was 18 years (n 
12,091,363); those with missing data on patient age, sex,
admission date, discharge date, or in-hospital death (n 
252,617); discharges in which patients were admitted and
discharged alive the same day, because such events might
not have truly represented hospital stays for acute conditions
(n  1,0373,079); and discharges from states that did not
eport data for each year of the study period (n 
,648,462). The HF hospital stays were classified as those
ith a principal discharge diagnosis of HF on the basis ofhe following International Classification of Diseases-9th sevision-Clinical Modification
ICD-9-CM) codes: 402.01;
02.11; 402.91; 404.01; 404.03;
04.11; 404.13; 404.91; 404.93;
nd 428.
tatistical analyses. We conducted
pre-specified analysis calculating
opulation-based HF hospital stay
ates/100,000 persons for each cal-
ndar year, with the numerator
epresenting the number of HF
ospital stays and the denominator
epresenting the population 18 years of age and older from U.S.
ensus estimates for each state (12). Survey analysis methods
ere employed that used hospital-level discharge weights
rovided by the NIS to estimate the number of HF hospital
tays on a national level (13). The HF hospital stay rates
ere calculated for the overall cohort and for subgroups of
ge (18 to 45, 45 to 54, 55 to 64, 65 to 74, and 75 years),
ex, and, insurance status (Medicare, Medicaid, private
nsurance [including health maintenance organizations],
elf-pay, no charge, and other). Because a denominator
opulation of individuals specifying particular types of
ealth insurance could not be constructed for each year,
ifferences in HF hospital stay rate by insurance status were
ot estimated. Differences in LOS and in-hospital mortality
ates were able to be evaluated by insurance status, because
alculation of these rates used the hospital stay as the unit of
nalysis. Comorbidities were identified from ICD-9-CM
econdary diagnosis codes and were classified according to
ierarchical condition categories, similar to those used by
he Centers for Medicare and Medicaid Services for calcu-
ating their 30-day HF mortality measure (14). To evaluate
hether HF hospital stay rates declined faster than the
verall any-cause hospital stay rate, we calculated the
ospital stay rate/100,000 persons for all principal diagnoses
ver the study period.
In-hospital survival curves were constructed that assumed
hat the discharge date recorded in NIS was the date of
eath, where the denominator represented the number of
atients still hospitalized on a given hospital day, and the
umerator represented the number of patients who were not
ecorded as having an in-hospital death on that hospital day.
urvival curves were generated for 3-year periods (2001 to
003, 2004 to 2006, and 2007 to 2009) to examine how
ggregate in-hospital mortality changed over the study
eriod.
Statistical significance of the annual changes in HF
ospital stay rate and in-hospital mortality were assessed
ith Poisson regression that included a variable represent-
ng the linear trend from the baseline year of 2001; a similar
nalysis was conducted for LOS with linear regression. All
values were 2-sided with a significance threshold of p 
.001. Statistical analyses were performed with SAS (ver-
Abbreviations
and Acronyms
HF  heart failure
ICD-9-CM  International
Classification of Diseases,
9th revision, Clinical
Modification
LOS  length of stay
NIS  National Inpatient
Sampleion 9.2, SAS Institute, Cary, North Carolina).
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Our analytic cohort consisted of 48,305,918 hospital stays
for any principal discharge diagnosis across 29 states that
reported data for each year between 2001 and 2009, of
which 1,686,089 hospital stays were for a principal dis-
charge diagnosis of HF. This represents, after applying
sampling weights to calculate the number of national
discharges for HF from the NIS sample, an estimated
8,249,759 HF hospital stays in the United States from 2001
to 2009. The HF patients were predominantly elderly
individuals, with slightly more than one-half of the cohort
75 years of age and older (Table 1). In 2001 there were
slightly more women than men (55% vs. 45%), which
diminished by 2009 (50.6% vs. 49.4%). Most patients were
white; the proportion of patients with unknown race de-
creased from 27.7% to 10.7% as more states reported race
data to NIS over the study period.
Approximately three-quarters of the patients hospitalized
with HF had Medicare insurance coverage. Most (90.9%)
HF patients 65 years of age and older were insured by
Medicare; most HF patients younger than 65 years of age
were covered by insurance other than Medicare (69.6%),
including private health insurance (30.4%) and Medicaid
(23.5%) (Fig. 1).
Several comorbidities were more prevalent over the study
period, including renal failure (from 11.7% to 44.4%,
p-for-trend 0.001), hypertension (39.7% to 59%, p-for-
trend 0.001), and cardiorespiratory failure or shock (7.2%
to 15.7%, p-for-trend  0.002).
HF hospital stay rate. The national HF hospital stay rate
declined from 633 to 463 hospital stays/100,000 persons
from 2001 to 2009, a relative 26.9% decrease (p-for-trend
0.001) (Table 2). The aggregate hospital stay rate for any
principal diagnosis also fell (from 17,087 to 14,183/100,000
persons, p-for-trend 0.001), a relative 17% decrease that
was not statistically different than the HF hospital stay rate
(p  0.002). Statistically significant declines in the HF
hospital stay rate were observed for patients 55 to 64 years
of age (from 704 to 447/100,000 persons, 36.5%, p-for-
trend0.001), 65 to 74 years (from 1,709 to 1,070/100,000
ersons, 37.4%, p-for-trend 0.001) and 75 years
from 4,272 to 3,064/100,000 persons, 28.3%, p-for-
rend 0.001). No statistically significant changes in HF
ospital stay rates were observed for ages 18 to 44 (from 44
o 38/100,000 persons, 12.8%, p-for-trend  0.57) or 45
to 54 years (from 247 to 207/100,000 persons, 16.2%,
p-for-trend  0.04) (Fig. 2). The HF hospital stay rate
declined for women (from 676 to 457/100,000 persons,
32.3%, p-for-trend 0.0001) and also declined for men
but did not reach statistical significance (from 588 to
469/100,000 persons, 20.2%, p-for-trend  0.003). Sta-
tistically significant declines in the HF hospital stay rate
were observed in 5 of the 9 U.S. census regions.
Sensitivity analyses that examined age categories in 5-year
intervals and found that patients 55 years of age and older dhad statistically significant declines in the HF hospital stay
rate (p  0.001) with marginal statistical significance for
patients 45 to 49 years and 50 to 54 years of age (p  0.07
and p  0.01, respectively); no statistically significant
declines in HF hospital stay rates were found for patients in
5-year age categories 45 years (all p  0.54).
In secondary analyses of 36,229,163 patients hospitalized
in the 20 states that reported complete data on patient race,
the overall decline in HF hospital stay rate was 24.7%
(p-for-trend 0.001), comparable to the primary analysis
examining all states. Statistically significant declines were
observed for white and black women (white women,
33.5%; black women, 30.9%). White men had a non-
statistically significant decrease in HF hospital stay rate
(24.7%, p-for-trend  0.003), whereas black men did not
have a statistically significant change in HF hospital stay
rate (9.5%, p-for-trend  0.43) over the study period.
mong patients 75 years of age or older, there was no
ignificant difference (p  0.59) between the change in HF
ospital stay rate over time between black men (29.8%,
-for-trend 0.001) and white men (26.0%,
-for-trend0.001) (Online Table 1). Although changes in
F hospital stay rate over time were not statistically
ignificant for either black or white men younger than 55
ears, there was essentially no change in the point estimates
f relative change of HF hospital stay rate for black men 18
o 44 years (2.7%, p-for-trend  0.70) or 45 to 54 years
3.7%, p-for-trend 0.02) in contrast to white men 18 to
4 years (21%, p-for-trend  0.55) or 45 to 54 years
17.6%, p-for-trend  0.08).
OS. Observed mean LOS for HF hospital stay fell from
.6 days to 5.3 days, a relative 6.4% decline (p-for-trend
0.001) (Table 3). Median LOS was 3.7 days in 2001 (25th
o 75th percentile: 2.1 to 6.3 days), which declined to 3.5
ays (25th to 75th percentile: 2.0 to 5.9 days) by 2009
p-for-trend 0.001). Examined across patient age, statis-
ically significant declines in LOS were only observed for
hose 75 years and older (8.5%, p-for-trend 0.001).
tatistically significant declines in LOS for HF hospital
tays were observed for Medicare patients (7.1%, p-for-
rend0.001), whereas those with other insurance coverage
ere not associated with significant changes over time. The
id Atlantic census region had the largest decline in LOS
13.1%, p-for-trend 0.001). Secondary analyses were
erformed examining with renal failure or cardiorespiratory
ailure/shock, 2 comorbidities with large increases in prev-
lence over time. Patients with renal failure or cardiorespi-
atory failure/shock had significantly longer LOS (p 
.001), compared with patients without renal failure or
ardiorespiratory failure/shock. Declines in LOS were
teeper for patients with renal failure or cardiorespiratory
ailure/shock, compared with patients without renal failure
r cardiorespiratory failure/shock.
In secondary analyses among patients hospitalized in
tates that reported complete race data, the overall
ecline in LOS was 7.9% (p-for-trend 0.001). Statis-
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March 12, 2013:1078–88 Trends in Heart Failure Hospital StayCharacteristics of Patients Hospitalized for HFTable 1 Characteristics of Patients Hospitalized for HF
Description 2001 2002 2003 2004 2005 2006 2007 2008 2009 p-for-trend
HF hospital stays, n 999,801 948,849 946,043 970,085 965,377 931,124 882,364 803,318 802,796 0.001
Age (yrs)
18 to 45 3.7 4.0 4.0 4.2 4.2 4.4 4.5 4.3 4.1 0.048
45 to 55 7.2 7.9 7.8 8.2 8.1 8.8 8.9 8.5 8.6 0.004
55 to 65 13.0 13.5 14.1 14.1 13.7 14.1 14.4 14.3 14.3 0.005
65 to 75 22.9 22.7 22.0 21.5 21.0 20.4 20.4 20.0 20.3 0.001
75 53.2 52.0 52.1 52.0 53.0 52.2 51.9 52.9 52.7 0.942
Sex
Male 45.0 45.6 46.1 47.1 48.3 48.7 48.9 49.3 49.4 0.001
Female 55.0 54.4 53.9 52.9 51.7 51.3 51.1 50.7 50.6 0.001
Race
White 51.6 51.3 49.3 51.3 53.3 50.1 50.3 54.6 58.9 0.080
Black 12.2 14.1 13.7 15.0 12.0 14.9 15.7 15.3 17.2 0.019
Hispanic 5.9 6.3 8.3 6.6 6.4 7.7 6.9 6.9 8.2 0.167
Other 2.6 3.1 2.9 3.0 2.7 2.9 3.5 4.5 5.0 0.008
Unknown 27.7 25.2 25.8 24.1 25.5 24.3 23.6 18.8 10.7 0.009
Primary insurance
Medicare 75.6 76.0 76.4 75.2 76.5 75.4 74.0 73.8 73.8 0.014
Medicaid 6.6 6.9 7.4 7.5 7.3 7.7 7.6 7.5 8.0 0.003
Private including HMO 13.7 12.8 11.9 12.4 11.5 11.6 12.7 13.5 12.5 0.780
Self-pay 2.5 2.5 2.3 3.0 3.1 3.2 3.3 3.1 3.8 0.001
No charge 0.2 0.2 0.3 0.4 0.3 0.4 0.5 0.4 0.4 0.003
Other 1.4 1.5 1.6 1.6 1.2 1.7 1.8 1.7 1.5 0.241
Census region
New England 4.6 5.3 5.0 6.6 6.1 6.4 6.9 5.6 5.6 0.161
Mid Atlantic 10.9 11.7 13.0 15.3 15.8 17.4 16.1 12.2 14.0 0.215
South Atlantic 24.2 26.1 26.4 25.3 24.9 24.4 25.0 26.5 26.7 0.340
West South Central 17.8 13.1 11.9 11.3 10.8 10.7 12.1 13.0 12.1 0.174
East South Central 6.6 7.1 8.2 7.4 7.5 7.4 5.5 6.4 5.8 0.122
West North Central 10.8 10.5 10.5 9.8 9.4 10.4 9.4 10.3 9.9 0.133
East North Central 10.5 9.4 9.7 9.9 10.5 8.5 9.7 9.3 9.5 0.243
Mountain 1.3 1.7 1.5 1.6 1.4 1.4 1.6 2.0 1.6 0.157
Pacific 13.1 15.1 13.9 12.8 13.5 13.3 13.8 14.8 14.7 0.395
Cardiovascular
PCI 4.3 4.5 4.6 4.8 5.4 5.9 6.4 7.2 7.2 0.001
CABG 13.7 13.5 13.1 13.3 13.5 13.8 13.6 14.0 13.9 0.111
Acute myocardial Infarction 2.4 2.4 2.5 2.4 2.5 2.2 2.3 2.3 2.4 0.244
Unstable angina 4.0 3.8 3.5 3.3 3.1 2.9 2.7 2.7 2.5 0.001
Chronic atherosclerosis 47.9 48.1 48.8 49.4 50.1 49.8 50.8 52.0 52.4 0.001
Cardiorespiratory failure (shock) 7.2 7.4 7.6 7.8 7.2 9.0 11.4 12.3 15.7 9.002
Valvular or rheumatic Heart disease 17.7 18.4 19.2 19.7 20.8 21.2 21.6 21.0 21.9 0.001
Comorbidity
Hypertension 39.7 42.3 43.4 43.9 43.5 43.6 54.3 57.1 59.0 0.001
Stroke 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.031
Renal failure 11.7 13.2 14.9 16.8 21.8 32.7 37.6 40.8 44.4 0.001
COPD 29.1 30.1 30.5 31.2 31.7 31.5 32.1 30.5 31.1 0.064
Pneumonia 7.2 7.7 8.1 8.3 9.7 11.8 12.9 14.0 14.6 0.001
Diabetes and complications 39.8 40.5 40.7 40.5 40.3 40.5 41.8 42.2 42.8 0.002
Protein-calorie malnutrition 1.6 1.5 1.6 1.9 2.0 1.9 2.3 2.8 3.4 0.001
Dementia and senility 5.9 6.2 6.3 6.5 6.8 7.2 7.7 8.4 8.6 0.001
Hemiplegia, paralysis, functional disability 3.1 3.2 3.0 3.0 2.9 2.9 3.1 3.6 3.6 0.132
Vascular or circulatory disease 8.9 9.2 9.0 9.5 9.8 10.0 10.9 11.7 11.7 0.001
Metastatic cancer and acute leukemia 1.4 1.4 1.4 1.4 1.4 1.4 1.5 1.6 1.6 0.003
Trauma 2.2 2.5 1.4 1.5 1.5 1.5 1.7 1.9 1.9 0.415
Major psychological disorders 1.8 1.8 1.8 1.9 1.8 2.0 2.1 2.5 2.5 0.002
Liver and biliary disease 1.3 1.5 1.5 1.7 1.6 1.9 1.9 1.9 2.1 0.001Values are %.
CABG  coronary artery bypass surgery; COPD  chronic obstructive pulmonary disease; HF  heart failure; HMO  health maintenance organization; PCI  percutaneous coronary intervention.
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Trends in Heart Failure Hospital Stay March 12, 2013:1078–88tically significant reductions in LOS were observed for
white men (7.1%), white women (8.8%), and black
women (8.6%). The LOS fell over time for black men
(7.8%, p-for-trend  0.18) but did not reach statistical
significance.
In-hospital mortality. Observed in-hospital mortality for
HF patients fell from 4.5% to 3.3%, a relative decline of
27.4% (p-for-trend 0.001). There was increasingly higher
survival during the HF hospital stay across the first, middle,
and last thirds of the study period (Fig. 3). Statistically
Figure 1 Distribution Health Insurance Status,
by Age >65 Years and Age <65 Years
Distribution of heart failure patients in the Healthcare Cost & Utilization Project
according to health insurer type, stratified by patient age 65 years and 65
years. HMO  health maintenance organization.
Heart Failure Hospital Stay Rate/100,000 PersonsTable 2 Heart Failure Hospital Stay Rate/100,000 Persons
Description 2001 2002 2003 2004 2005
Overall 633 594 586 593 584
Age categories (yrs)
18 to 45 44 45 45 48 48
45 to 55 247 254 245 259 248
55 to 65 704 653 649 640 593
65 to 75 1,709 1,608 1,552 1,541 1,487
75 4,272 3,894 3,827 3,868 3,861
Sex
Male 588 558 557 575 580
Female 676 627 613 611 588
Census region
New England 521 567 528 721 660
Mid Atlantic 526 530 583 700 716
South Atlantic 723 728 724 698 670
West South Central 861 597 537 517 491
East South Central 891 901 1024 939 942
West North Central 810 738 730 695 660
East North Central 687 569 577 597 619
Mountain 277 329 284 308 263Pacific 395 427 385 359 374significant reductions in in-hospital mortality were observed
for patients 45 to 54 years (21.7%), 55 to 64 years
(35.7%), 65 to 74 years (29%), and 75 years of age or
older (25.4%); however, patients 18 to 44 years of age did
not exhibit a significant decline in in-hospital mortality
(8.1%, p  0.18) (Table 4). Patients with Medicare,
Medicaid, private insurance, and self-pay coverage had
significant declines in in-hospital mortality. Improvements
in in-hospital mortality were observed across all census
regions, except for the New England and Mountain regions.
Similar to LOS, patients with renal failure or shock had
significantly higher in-hospital mortality compared with
patients without renal failure or shock and faster rates of
decline over the study period.
In secondary analysis, the overall decline in in-hospital
mortality restricted to states reporting complete patient race
data was statistically significant (29.1%, p-for-trend
0.001) and similar to the primary analysis. All race-sex
groups exhibited statistically significant declines in in-
hospital mortality: white men (27.7%); white women
(24.6%); black men (39.2%); and black women
31.7%) (p-for-trend 0.001).
iscussion
ith a national all-payer database of hospital discharges in
he United States, we found that the overall national HF
ospital stay rate fell by a relative 26.9% from 2001 to 2009.
his decline is similar in magnitude to the 29.5% decrease
n HF hospital stay rates observed in the Medicare popu-
ation from 1998 to 2008 (1). However, our study adds to
rior work by demonstrating the HF hospital stay rate did
2006 2007 2008 2009
(2001–2009)
Relative Change p-for-trend
556 521 469 463 26.9% 0.001
49 47 41 38 12.8% 0.570
257 241 207 207 16.2% 0.036
563 526 462 447 36.5% 0.001
,372 1,266 1,089 1,070 37.4% 0.001
,624 3,373 3,102 3,064 28.3% 0.001
557 523 474 469 20.2% 0.003
556 520 464 457 32.3% 0.001
664 672 492 490 5.9% 0.551
757 663 452 518 1.5% 0.804
623 594 567 563 22.1% 0.001
465 497 482 450 47.8% 0.001
884 606 640 578 35.1% 0.001
695 589 581 555 31.5% 0.001
472 499 424 424 38.2% 0.001
249 253 289 226 18.3% 0.0111
3353 342 330 322 18.5% 0.003
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March 12, 2013:1078–88 Trends in Heart Failure Hospital Staynot decrease significantly for patients 18 to 44 years and 45
to 55 years of age, indicating that trends for HF hospital
stay rate observed for older Medicare patients do not
necessarily apply to younger populations. An Australian
study of HF hospital stay trends (15) also found that
reductions in the HF hospital stay rate was predominately
limited to older populations: from 1990 to 1993 to 2002 to
2005 the HF hospital stay rate fell by 44% for men and by
46.5% for women 65 to 74 years of age, but the decline in
HF hospital stay rate was much slower for women 65
years (11.5%) and in fact increased slightly over time for
men (1.7%).
Although the overall reduction in the HF hospital stay
rate represents a success, our findings illustrate that chal-
lenges remain for ensuring comparable improvements for
younger patients. One possible explanation for the lack of
decline in HF hospital stay for younger patients is that HF
risk factor control might have improved more in older
patients. For example, hypertension is an important cause of
diastolic HF (16), but hypertension awareness and treat-
ment is considerably lower for younger patients 40 years
compared with those 40 years (17,18). Coronary artery
disease is another major cause of HF that is more prevalent
with older age, and the declines in ischemic heart disease
events over the past decade in observed older patients (19)
might have been less dramatic for younger patients. Other
causes of heart failure, such as infectious etiologies and
peripartum cardiomyopathy commonly manifest at younger
ages (20), and the incidence of these conditions might not
have declined as rapidly as HF etiologies found more
frequently in older patients.
Our overall findings of substantial decreases in HF
hospital stay rates over time are consistent with reports from
several countries. In Sweden (1988 to 2000) (21), the
Figure 2 Heart Failure Hospital Stay Rate by Age Category/10
Heart failure hospital stay rate/100,000 over time from 2001 to 2009, stratifiedNetherlands (1980 to 1999) (22), a New Zealand study(1988 to 2008) (23), and Scotland (1986 to 1999) (24), the
HF hospital stay rates peaked in the 1990s, with significant
declines afterward. Two studies outside of the United States
have evaluated HF hospital stay trends since 2000. In
Canada (25) the overall age-standardized HF rate (includ-
ing hospital stays and outpatient clinic and emergency
department visits) decreased by 25.1% from 1999 to 2007
(25); faster declines in HF hospital stay rate alone were
observed. In New Zealand (23) the HF hospital stay rate
peaked in 1998 to 1999 and decreased by 28.6% for men
and 31.2% for women until 2008. Thus, the decline in the
HF hospital stay rate over the most recent decade seems in
line with observations from other developed nations.
Reasons for the decline in HF hospital stay rate are likely
multifactorial. One possibility is that control of risk factors
leading to HF have improved over time. For example,
hypertension control in the United States has increased
from 27.3% from 1988 to 1994 to 50.1% in 2007 to 2008
(17). Incidence of ischemic heart disease has decreased
dramatically over the past decade (19,26), with parallel
increases in the use of angiotensin-converting enzyme
inhibitors, angiotensin receptor blockers, beta-blockers, and
statins in the United States (19). Another contributor to the
decline in HF hospital stay rate might be due to shifting of
location of HF care from hospitals to emergency depart-
ment or outpatient settings. The Canadian study found a
greater proportion of HF cases diagnosed in outpatient
clinics and emergency departments over time, with HF
incidence rates declining faster for hospitals compared with
other clinical settings (25); nevertheless, the overall HF
incidence rate from all locations fell over time, suggesting
that there has been some overall reduction in HF incidence
as well in Canada. A U.S. study examining Medicare
0 Persons
categories.0,00
by agehospital and outpatient billing claims found a modest
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ing from 32 to 29/1,000 person-years (27).
Our study found that trends in LOS also diverged
according to patient age. Although patients of typical
Medicare age (65 years) had statistically significant
reductions in LOS over the study period, this was not the
case for patients younger than 65 years. Understanding
the reasons for the lack of decline in LOS in younger
patients will ultimately require clinical data, but we
speculate that it might be related in some part to
differences in comorbidity burden. Older patients typi-
cally have multiple comorbidities and thereby perhaps
more opportunities to reduce LOS through more inten-
sive use of skilled nursing facilities or increased referral to
hospice, both of which have increased in the Medicare
population over the past decade (28).
Our study also noted divergence across age groups for
Mean Length of Stay for Heart Failure Hospital StayTable 3 Mean Length of Stay for Heart Failure Hospital Stay
Description 2001 2002 2003 2004
All 5.6 5.6 5.6 5.6
Age categories (yrs)
18 to 45 5.1 5.1 5.1 5.0
45 to 55 5.2 5.2 5.2 5.2
55 to 65 5.6 5.6 5.5 5.6
65 to 75 5.7 5.7 5.6 5.6
75 5.7 5.7 5.6 5.7
Sex
Male 5.6 5.5 5.5 5.5
Female 5.7 5.7 5.6 5.7
Insurance status
Medicare 5.7 5.7 5.6 5.6
Medicaid 6.1 5.9 6.0 5.9
Private including HMO 5.3 5.1 5.1 5.2
Self-pay 4.8 4.9 4.7 5.0
No charge 5.0 5.4 4.7 5.1
Other 5.0 5.4 5.4 4.9
Census region
New England 5.6 5.3 5.2 5.4
Mid Atlantic 7.3 7.2 6.7 7.0
South Atlantic 5.4 5.4 5.5 5.3
West South Central 5.3 5.3 5.3 5.3
East South Central 5.5 5.7 5.5 5.5
West North Central 5.4 5.4 5.2 5.3
East North Central 6.0 5.9 5.9 5.7
Mountain 5.2 4.9 5.0 4.8
Pacific 5.3 5.2 5.2 5.1
Selected comorbidities
Renal failure
No 5.3 5.2 5.1 5.1
Yes 8.5 8.5 8.2 8.1
Cardiorespiratory failure (shock)
No 5.3 5.2 5.2 5.2
Yes 10.1 10.3 10.1 10.1
Values are %.
HMO  health maintenance organization.in-hospital mortality, with no significant change for patients18 to 44 years of age but significant decreases for older
patients. This might be due to differences in HF etiology or
severity of illness in younger adults compared with older
adults. Differences in discharge disposition might again play
a role. Although in-hospital mortality has decreased over
the past decade among Medicare patients, 30-day mortality
has decreased at a slower rate due to a greater proportion of
deaths that occur after discharge from HF hospital stay (28).
As with LOS, the lack of improvement in in-hospital
mortality might potentially be explained if a greater number
of older patients were discharged to or died in non-hospital-
based facilities, whereas younger patients were more likely
to remain hospitalized until they died. Because the NIS
does not track individual patients after hospital discharge,
this hypothesis will need to be verified with other sources of
data.
The prevalence of comorbidities of patients hospitalized
2006 2007 2008 2009
(2001–2009)
Relative Change p-for-trend
5.4 5.4 5.3 5.3 6.4% 0.001
4.9 5.0 5.3 5.0 2.0% 0.559
5.0 5.0 5.1 5.1 1.8% 0.553
5.3 5.4 5.4 5.5 2.7% 0.061
5.5 5.4 5.4 5.4 5.0% 0.007
5.5 5.4 5.3 5.3 8.5% 0.001
5.3 5.3 5.3 5.2 5.5% 0.003
5.5 5.4 5.4 5.3 6.9% 0.001
5.5 5.4 5.4 5.3 7.1% 0.001
5.6 5.9 5.7 5.6 7.3% 0.074
5.0 4.9 5.1 5.2 2.6% 0.090
4.8 4.8 4.6 4.8 1.5% 0.268
4.7 5.5 5.3 5.0 1.1% 0.349
4.9 5.1 4.9 4.9 2.1% 0.396
5.2 5.4 5.6 5.1 8.4% 0.787
6.5 6.4 6.3 6.3 13.1% 0.001
5.2 5.2 5.2 5.2 4.1% 0.131
5.0 5.0 5.2 4.9 6.2% 0.093
5.3 5.2 5.2 5.1 6.7% 0.436
4.9 5.0 5.0 4.8 9.8% 0.058
5.4 5.4 5.4 5.5 8.5% 0.056
4.7 4.9 5.1 4.8 8.5% 0.133
5.1 5.0 5.2 5.1 3.8% 0.635
4.7 4.7 4.6 4.6 13.7% 0.001
6.7 6.5 6.4 6.2 26.6% 0.001
5.1 5.0 5.0 4.8 8.6% 0.001
8.7 8.2 8.1 7.7 24.3% 0.0012005
5.5
5.0
5.1
5.3
5.5
5.6
5.4
5.6
5.5
5.8
5.1
4.6
5.2
4.9
5.4
6.7
5.2
5.1
5.4
5.2
5.6
4.6
5.1
4.9
7.4
5.1
9.8for HF increased over time in our study sample. This is
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population (29), demonstrating an increase in the comor-
bidity of hospitalized HF patients. Other countries have
also documented increasing comorbidities. For example, in
Western Australia the proportion of HF patients with renal
failure increased from 6.3% to 17.3%, and the proportion of
HF patients with diabetes mellitus increased from 18.5% to
26.9% (15); in Scotland, the proportion of male HF patients
with renal failure increased from 4.1% to 18.5%, and the
proportion of male HF patients diabetes mellitus increased
from 7.6% to 19.4% (24). These findings either represent a
true clinical increase in the burden of comorbidity or are
explained by the additional coding of secondary diagnoses
over time. The National Health and Nutrition Examination
Survey reports that the prevalence of several comorbidities
has increased over time in HF patients—renal disease
increased by 11.2% from 1988 to 2008, diabetes increased
by 13.6%, and obesity increased by 14% (30). These data, on
the basis of patient interviews and examination of subjects,
strongly suggest that the comorbidity profile of HF patients
has worsened over time. Although it is possible that
hospitals might have been more aggressive in coding sec-
ondary diagnoses over time for reimbursement purposes,
such “upcoding” (31) seems unlikely to fully explain the
increase in comorbidities seen in cohorts in Australia,
Scotland, and the U.S. Veterans Administration, given that
these are government-run health care systems with little
incentive to upcode for added reimbursement. Furthermore,
substantial upcoding would alter the relationship between
comorbidity and outcomes (such as mortality) as more
patients with less severe comorbidities were included. How-
ever, this does not seem to be the case, at least in the
Medicare population, because the coefficients of the CMS
HF mortality model have remained stable from 2005 to
2008 (32,33).
Our secondary analyses of patients with renal failure or
Figure 3 In-Hospital Survival for Heart Failure Hospital Stay, by
Proportion of hospitalized heart failure patients who remain alive by hospital day,cardiorespiratory failure/shock confirm that patients withthese comorbidities were indeed more complex, with higher
LOS and in-hospital mortality than patients without these
comorbidities. Although the steeper decline over time in
LOS and in-hospital mortality for patients with renal failure
or cardiorespiratory failure/shock might potentially indicate
that additional patients with less severe comorbidity were
coded over time, this would also occur if patients with renal
failure or cardiorespiratory failure (shock) were more likely
to be discharged to skilled nursing facilities or hospice over
the study period. Ultimately, studies using clinical data will
be required to determine whether the increase in comor-
bidities reflect a higher threshold for HF hospital stay,
differences in coding of secondary diagnoses, or more
intensive use of post-discharge facilities over time.
Secondary analyses also confirm that the HF hospital stay
rate fell more slowly for black men compared with other
race-sex groups. A prior study of Medicare beneficiaries (1)
also reported that reductions in HF hospital stay rate lagged
for black men, but until this time no large-scale study had
provided verification in a general non-Medicare population.
A small study analyzed hospital discharge data from Ten-
nessee from 1997 to 2006 and reported that black men had
a 28.2% increase in age-adjusted HF hospital stay rate (34),
higher compared with other race-sex groups (range 4.0% to
11.7%). Taken together, these studies strongly suggest that
black men represent a particularly vulnerable population for
HF hospital stay.
We speculate that black men had a slower rate of decline
in HF hospital stays in part due to differences in risk factor
management. The Multi-Ethnic Study of Atherosclerosis
and the Coronary Artery Risk Development in Young
Adults study suggested that the excess risk of developing
HF among black patients was primarily due to higher rates
of hypertension, obesity, and diabetes mellitus (2,35). Prev-
alence of obesity and diabetes mellitus have increased faster
in black men compared with other race-sex groups (36,37).
ital Day
ed by time periods 2001 to 2003, 2004 to 2006, and 2007 to 2009.Hosp
stratifiHypertension has increased over the past 2 decades for men
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blood pressure screening, awareness, treatment, and control
of hypertension compared with other race-sex groups
(38,39). It was reassuring, however, to observe that the
decline in in-patient mortality for black men hospitalized
for HF was comparable to other race-sex groups. Of note,
in-hospital mortality rates for black patients were lower than
in white patients, a finding also observed in other studies
(40,41); the reason for this phenomenon is not well-
understood, because black HF patients have been found to
receive comparable quality of HF care, as assessed by use of
angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers (41); the lower in-hospital mortality rate
among black patients might represent differences in HF
etiology, disease progression, or severity of HF among
hospitalized patients.
Study limitations. HF hospital stays were identified
In-Hospital Mortality for Heart Failure Hospital Stay/100Table 4 In-Hospital Mortality for Heart Failure Hospital Stay/10
Description 2001 2002 2003 2004
ALL 4.5 4.3 4.2 4.0
Age categories (yrs)
18 to 45 1.7 1.6 1.6 1.7
45 to 55 1.6 1.7 1.7 1.7
55 to 65 2.7 2.4 2.3 2.4
65 to 75 3.6 3.5 3.3 3.2
75 6.0 5.8 5.6 5.4
Sex
Male 4.7 4.5 4.2 4.1
Female 4.4 4.1 4.1 3.9
Insurance status
Medicare 4.9 4.7 4.5 4.3
Medicaid 2.6 2.5 2.6 2.3
Private including HMO 3.8 3.1 3.3 3.3
Self-pay 2.3 2.1 1.9 2.6
No charge 1.7 0.8 1.1 2.3
Other 4.6 5.2 6.5 5.1
Census Region
New England 5.0 4.6 4.1 4.1
South Atlantic 4.3 3.8 3.9 3.7
West South Central 3.9 3.5 3.9 3.5
East South Central 4.5 4.7 4.6 4.5
West North Central 4.8 4.5 3.9 4.0
East North Central 4.8 4.4 4.2 3.8
Mountain 4.1 4.1 3.9 3.9
Pacific 4.6 4.3 4.4 4.0
Selected comorbidities
Renal failure
No 3.6 3.3 3.2 3.0
Yes 11.3 10.5 9.7 9.0
Cardiorespiratory failure (shock)
No 3.0 2.7 2.6 2.5
Yes 24.7 23.8 22.7 22.4
Values are %.
HMO  health maintenance organization.hrough ICD-9 codes and not clinically confirmed. TheICD-9-CM codes have high specificity (approximately
95%) and positive predictive value for HF (approximately
95%) (42–49), but our findings would only be affected if
HF coding patterns changed over time. Second, we were
neither able to examine subcategories of HF (i.e., systolic
vs. diastolic HF, and ischemic vs. nonischemic HF) nor
able to assess severity of HF hospital stay, such as use of
care in the intensive care unit. Third, the NIS does not
track individual patients over time, and as such we were
unable to determine whether changes in HF hospital stay
rates represented declines in unique individuals hospital-
ized or declines in readmission after index HF hospital
stays. Similarly, we were unable to assess whether the
decline in HF hospital stays presented a decrease in incident
or prevalent cases; however, studies of Medicare patients
suggest that the decline in HF hospital stay rate was almost
entirely due to new cases (1). Not all stages reported data for
2006 2007 2008 2009
(2001–2009)
Relative Change p-for-trend
3.6 3.3 3.3 3.3 27.4% 0.001
1.4 1.4 1.4 1.5 8.1% 0.181
1.3 1.3 1.3 1.3 21.7% 0.001
1.9 1.7 1.6 1.7 35.7% 0.001
2.8 2.5 2.5 2.5 29.0% 0.001
4.9 4.6 4.5 4.5 25.4% 0.001
3.5 3.2 3.3 3.3 30.5% 0.001
3.6 3.4 3.4 3.3 24.8% 0.001
3.9 3.6 3.6 3.6 27.4% 0.001
1.8 1.8 1.8 1.7 32.5% 0.001
3.0 3.1 2.9 3.0 21.0% 0.009
1.7 1.7 1.6 1.1 52.1% 0.001
1.2 1.8 0.6 2.3 33.2% 0.757
3.7 3.8 4.8 6.0 31.2% 0.660
4.0 3.4 3.7 3.8 23.3% 0.001
3.1 2.9 2.8 3.1 28.8% 0.001
3.3 2.9 2.8 3.0 23.7% 0.001
3.6 3.6 3.7 3.4 23.5% 0.001
3.7 3.5 3.6 3.6 25.0% 0.001
3.4 3.1 2.9 2.9 39.5% 0.001
3.5 3.6 3.5 2.9 29.4% 0.006
3.7 3.6 3.8 3.3 27.9% 0.001
2.6 2.3 2.5 2.3 36.8% 0.001
5.5 4.9 4.6 4.5 60.0% 0.001
2.2 2.0 2.0 1.8 39.6% 0.001
16.7 13.1 12.9 11.3 54.2% 0.0010
2005
3.8
1.2
1.6
1.9
2.9
5.2
3.8
3.8
4.1
1.8
3.2
2.1
1.4
4.7
3.9
3.2
3.3
4.1
4.1
3.5
2.8
3.9
2.8
7.2
2.4
21.6all years to NIS, which may limit national representative-
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examining a complete sample of Medicare patients with HF
over a similar timeframe (1). Lastly, we were only able to
examine in-hospital outcomes and were not able to assess
whether declines in inpatient mortality might have resulted
from the trends towards shorter LOS. We were unable to
examine whether post-discharge mortality increased to off-
set improved inpatient outcomes.
Conclusions
With a large all-payer population of U.S. adults, we ob-
served a 26.9% decrease in the overall adjusted HF hospital
stay rate from 2000 to 2009, but younger patients have not
experienced declines in HF hospital stay, LOS, and in-
hospital mortality comparable to older patients. Black men
remain a vulnerable group with no significant decline in HF
hospital stay rate over the past decade.
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